View Item 

Show simple item record

Primary care physician beliefs about insulin initiation in patients with type 2 diabetes

dc.contributor.authorHayes, Risa P.en_US
dc.contributor.authorFitzgerald, J. Thomasen_US
dc.contributor.authorJacober, Scotten_US
dc.date.accessioned2010-06-01T18:33:51Z
dc.date.available2010-06-01T18:33:51Z
dc.date.issued2008-06en_US
dc.identifier.citationHayes, R. P.; Fitzgerald, J. T.; Jacober, S. J. (2008). "Primary care physician beliefs about insulin initiation in patients with type 2 diabetes." International Journal of Clinical Practice 62(6): 860-868. <http://hdl.handle.net/2027.42/71769>en_US
dc.identifier.issn1368-5031en_US
dc.identifier.issn1742-1241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71769
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18393965&dopt=citationen_US
dc.format.extent143879 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJournal compilation © 2008 Blackwell Publishing Ltden_US
dc.titlePrimary care physician beliefs about insulin initiation in patients with type 2 diabetesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Medical Education, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherGlobal Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USAen_US
dc.contributor.affiliationotherLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USAen_US
dc.identifier.pmid18393965en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71769/1/j.1742-1241.2008.01742.x.pdf
dc.identifier.doi10.1111/j.1742-1241.2008.01742.xen_US
dc.identifier.sourceInternational Journal of Clinical Practiceen_US
dc.identifier.citedreferenceBrown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004; 27: 1535 – 40.en_US
dc.identifier.citedreferenceNathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963 – 72.en_US
dc.identifier.citedreferencePeyrot M, Rubin RR, Lauritzen T et al. The International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005; 28: 2673 – 9.en_US
dc.identifier.citedreferencePolonsky WHL, Fisher L, Guzman S et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005; 28: 2543 – 5.en_US
dc.identifier.citedreferenceHunt LM, Valenzuela MA, Pugh JA. NIDDM patients’ fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care 1997; 20: 292 – 8.en_US
dc.identifier.citedreferenceRiddle MC. The underuse of insulin therapy in North America. Diabetes Metab Res Rev 2002; 18 ( Suppl. 3 ): S42 – 9.en_US
dc.identifier.citedreferenceGrant RW, Wexler DJ, Watson AJ et al. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care 2007; 30: 1448 – 53.en_US
dc.identifier.citedreferenceJanes GR. Diabetes in America. Chapter 26. Ambulatory Medical Care for Diabetes. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995 ( NIH publication: no. 95–1468 ).en_US
dc.identifier.citedreferenceWallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. QJM 2000; 93: 369 – 74, Review. No abstract available.en_US
dc.identifier.citedreferenceHayes R, Kaiser B, El-Kebbi I. Primary care physicians’ treatment decisions for patients with type 2 diabetes poorly controlled on orals. Diabetes 2003; 52: A262.en_US
dc.identifier.citedreferenceAnderson RM, Fitgerald JT, Funnell MM et al. The third version of the Diabetes Attitude Scale. Diabetes Care 1998; 21: 1403 – 7.en_US
dc.identifier.citedreferenceWallace JI. Management of diabetes in the elderly. Clin Diabetes 1999; 17: 19 – 26.en_US
dc.identifier.citedreferenceMarker JC, Cryer PE, Clutter WE. Attenuated glucose recovery from hypoglycemia in the elderly. Diabetes 1992; 41: 671 – 8.en_US
dc.identifier.citedreferenceSakharova OV, Inzucchi SE. Treatment of diabetes in the elderly. Addressing its complexities in this high-risk group. Postgrad Med 2005; 118: 19 – 26, 29, Review.en_US
dc.identifier.citedreferencede Grauw WJC, van de Lisdonk EH, van Gerwen WHEM et al. Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life. Br J Gen Pract 2001; 51: 527 – 32.en_US
dc.identifier.citedreferencede Sonnaville JJJ, Snoek FJ, Colly LP et al. Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care 1998; 21: 919 – 24.en_US
dc.identifier.citedreferenceReza M, Taylor CD, Towse K et al. Insulin improves well-being for selected elderly type 2 diabetic subjects. Diabetes Res Clin Pract 2002; 55: 201 – 7.en_US
dc.identifier.citedreferenceWilson M, Moore MP, Lunt H. Treatment satisfaction after commencement of insulin in type 2 diabetes. Diabetes Res Clin Pract 2004; 66: 263 – 7.en_US
dc.identifier.citedreferenceBradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 2002; 18 ( Suppl. 3 ): S64 – 9.en_US
dc.identifier.citedreferenceHayes RP, Nakano M, Muchmore D et al. Effect of standard (self-directed) training versus intensive training for Lilly/Alkermes human insulin inhalation powder delivery system on patient-reported outcomes and patient evaluation of the system. Diabetes Technol Ther 2007; 9: 89 – 98.en_US
dc.identifier.citedreferenceRosenstock J, Cappelleri JC, Bolinder B et al. Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care 2004; 27: 1318 – 23.en_US
dc.identifier.citedreferenceRubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005; 118: 27S – 34S.en_US
dc.identifier.citedreferenceBrunton SA, White JR Jr, Renda SM. The role of basal insulin in type 2 diabetes management. J Fam Pract 2005; ( Suppl. ): S1 – 8.en_US
dc.identifier.citedreferenceAmerican Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2007; 30: S4 – 47.en_US
dc.identifier.citedreferenceVincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ 2004; 30: 112 – 25.en_US
dc.identifier.citedreferenceMollema ED, Snoek FJ, AdÈr HJ et al. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res 2001; 51: 665 – 72.en_US
dc.identifier.citedreferenceStratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405 – 12.en_US
dc.identifier.citedreferencePearson J, Powers MA. Systematically initiating insulin: the staged diabetes management approach. Diabetes Educ 2006; 32 ( Suppl. 1 ): 19S – 28S.en_US
dc.identifier.citedreference29 UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837 – 53.en_US
dc.identifier.citedreferenceMalmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314: 1512 – 5.en_US
dc.identifier.citedreferenceSun P, Buesching D, Engel-Nitz N et al. The relationship between the prevalence of cardiovascular disease and the use of insulin among patients with type 2 diabetes mellitus – a large national observational study in a managed care setting. Diabetologia 2007; 50 ( Suppl. 1 ): S47 ( Abstract 0099 ).en_US
dc.identifier.citedreferenceWeinberger M, Cohen SJ, Mazzuca SA. The role of physicians’ knowledge and attitudes in effective diabetes management. Soc Sci Med 1984; 19: 965 – 9.en_US
dc.identifier.citedreference33 American Medical Association. Physicians in Primary Care and Subspecialties by Gender. http://www.ama-assn.org/ama/pub/category/print/2687.html (accessed on January 2008).en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1742-1241.2008.01742.x.pdf
Size:
140.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.